Implementing high-value, cost-conscious diabetes mellitus care through the use of low-cost medications and less-intensive glycemic control target

Archives of Internal Medicine

Volumn 172, Issue 20, 2012, Pages 1610-1611

  Wilt, Timothy J ^a   Qaseem, Amir ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

COST EFFECTIVENESS ANALYSIS; DRUG COST; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATIENT CARE; PRIORITY JOURNAL;

DIABETES MELLITUS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; FEMALE; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84869143260     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/2013.jamainternmed.203     Document Type: Note

References (10)

1. Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156(3):218-231.
2. Margolis KL, O'Connor PJ. Prioritizing treatments in type 2 diabetes mellitus. Arch Intern Med. 2012;172(10):770-772.
3. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012;172(10):761-769.
4. Gellad W, Mor M, Zhao X, Donohue J, Good C. Variation in use of highcost diabetes mellitus medications in the VA healthcare system [published online October 8, 2012]. Arch Intern Med. 2012;172(20):1608-1609.
5. Duckworth W, Abraira C, Moritz T, et al VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. NEngl JMed. 2009;360(2):129-139.
6. The healthcare imperative: lowering costs and improving outcomes: workshop series summary. http: //iom. edu /Reports /2011 /The- Healthcare- Imperative- Lowering- Costs- and- Improving-Outcomes.aspx. Institute of Medicine website. Accessed August 6, 2012.
7. Owens DK, Qaseem A, Chou R, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174-180.
8. Weinberger SE. Providing high-value, cost-conscious care: a critical seventh general competency for physicians. Ann Intern Med . 2011;155(6): 386-388.
9. Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012; 156(2):147-149.
10. Best health tests and treatments often cost less. Consumer Reports. http: //www .consumerreports.org/cro/2012/04/best-health-tests-and-treatments-often -cost- less /index. htm. Accessed August 6, 2012.